Eliot Engel actually said...

The shroud of secrecy that veils the drug supply chain can make it challenging even for experienced health care professionals.

Due to the lack of transparency, my constituents often get a pricing surprise when they arrive at their pharmacy.

U.S. prescription drug spending rose by 41 percent between 2007 and 2017.

I agree with that assessment. But the Administration's intention to counter that appears to be through bilateral actions.